PARRISA RUPE: Open Payments
NPI 1326486572 · GALAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 44 payments from 14 companies in 2025. Trend: 2023 $368 · 2024 $744 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $175 |
| ABBVIE INC. | 12 | $149 |
| Novo Nordisk Inc | 3 | $73 |
| Amgen Inc. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| PFIZER INC. | 2 | $39 |
| Abbott Laboratories | 2 | $29 |
| Dexcom, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
Products named: HETLIOZ, VRAYLAR, FANAPT, Ozempic, OTEZLA, QULIPTA, FREESTYLE LIBRE 3, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
